Column Group LLC Portfolio Holdings

Column Group LLC

  • $71.2 Million
  • Q2 2024

Column Group LLC has filed its 13F form on August 15, 2024 for Q2 2024 where it was disclosed a total value porftolio of $71.2 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tenaya Therapeutics, Inc. with a value of $29.1M, Oric Pharmaceuticals, Inc. with a value of $25M, Surrozen, Inc. with a value of $8.87M, Rapt Therapeutics, Inc. with a value of $8.18M, and Revolution Medicines, Inc. with a value of $1K.

Examining the 13F form we can see an decrease of $89.2M in the current position value, from $160M to 71.2M.

Column Group LLC is based out at San Francisco, CA

Below you can find more details about Column Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $71.2 Million
Healthcare: $71.2 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.21B
$1,000 0.0% of portfolio
46
Q4 2023 Reduced 100.0%

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $71.2 Million
  • Prior Value $160 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 15, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Column Group LLC Portfolio

Follow Column Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email